Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiendl

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Tissue Antigens|October 10, 2006
Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosisD Buck, A Kroner, P Rieckmann, et al.
Der Nervenarzt|November 18, 2008
[Multiple sclerosis -- a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration]S G Meuth, N Melzer, C Kleinschnitz, et al.
Der Nervenarzt|September 26, 2014
[Prognostic and predictively relevant factors for multiple sclerosis]B Tackenberg, T Schneider-Hohendorf, A Müller, et al.
British Journal of Cancer|June 24, 2004
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic valueU Herrlinger, H Wiendl, M Renninger, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|April 5, 2013
[Concentric Sclerosis Baló: A rare Variant of Multiple Sclerosis]A J Höink, W Heindel, H Wiendl, et al.
Brain Pathology (Zurich, Switzerland)|August 30, 2003
March 2003: a 41 -year-old female with a solitary lesion in the liverH Wiendl, W Feiden, H Scherieble, et al.
Der Nervenarzt|April 7, 2005
[Blocking adhesion molecules with natalizumab in multiple sclerosis]B Schreiner, B C Kieseier, H-P Hartung, et al.
Clinical Neuropathology|February 16, 2002
Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA)F Duffner, R Ritz, A Bornemann, et al.
Clinical and Experimental Immunology|February 17, 2007
Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patientsU Feger, C Luther, S Poeschel, et al.
Der Nervenarzt|April 3, 2015
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]V I Leussink, C Warnke, B Tackenberg, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Tissue Antigens|October 10, 2006
Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosisD Buck, A Kroner, P Rieckmann, et al.
Der Nervenarzt|November 18, 2008
[Multiple sclerosis -- a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration]S G Meuth, N Melzer, C Kleinschnitz, et al.
Der Nervenarzt|September 26, 2014
[Prognostic and predictively relevant factors for multiple sclerosis]B Tackenberg, T Schneider-Hohendorf, A Müller, et al.
British Journal of Cancer|June 24, 2004
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic valueU Herrlinger, H Wiendl, M Renninger, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|April 5, 2013
[Concentric Sclerosis Baló: A rare Variant of Multiple Sclerosis]A J Höink, W Heindel, H Wiendl, et al.
Brain Pathology (Zurich, Switzerland)|August 30, 2003
March 2003: a 41 -year-old female with a solitary lesion in the liverH Wiendl, W Feiden, H Scherieble, et al.
Der Nervenarzt|April 7, 2005
[Blocking adhesion molecules with natalizumab in multiple sclerosis]B Schreiner, B C Kieseier, H-P Hartung, et al.
Clinical Neuropathology|February 16, 2002
Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA)F Duffner, R Ritz, A Bornemann, et al.
Clinical and Experimental Immunology|February 17, 2007
Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patientsU Feger, C Luther, S Poeschel, et al.
Der Nervenarzt|April 3, 2015
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]V I Leussink, C Warnke, B Tackenberg, et al.
Pageof 8